From: A midlife crisis for the mitochondrial free radical theory of aging
Genotype | Strain | N $ | 90th percentile survival (95% C.I.) [versus WT Control] | Survivorship effect? (P>0.05) | Reference |
---|---|---|---|---|---|
Single gene manipulations: | Â | Â | Â | Â | Â |
Mn superoxide dismutase | Â | Â | Â | Â | Â |
Sod2 Tg | C57BL/6 (males) | 50 | 1,165 d (1,092 to 1,245) [versus 1,128 d (1,080 to 1,206)] | No | [49] |
Sod2 Tg | Not indicated | 24 | N/A - 43.0Â months [versus 36.5Â months] and | N/A* | [52] |
Sod2 +/− | C57BL/6 (females) | 70 | 1,027 d (1,044 to 1,154) [versus 1,034 d (1,002 to 1,099)] | No | [53] |
CuZn superoxide dismutase | Â | Â | Â | Â | Â |
Sod1 Tg | C57BL/6 (male) | 44 | 1,121 d [versus 1,090 d] | No | [50] |
Sod1 Tg (homozygous) | CD1 | 119 | 30Â months [versus 31Â months]! | No | [54] |
Sod1 Tg (hemizygous) | CD1 | 200 | 31Â months [versus 31Â months]! | No | [54] |
Sod1 −/− | C57BL/6 | 10 | 762 d (761 to 767) [versus 1,076 d (1,035 to 1,298)] | Yes - decrease in mean lifespan | [51] |
Sod1 +/− | C57BL/6 | 12 | N/A - 28.7 ± 1.3 months [versus 29.8 ± 2.1 months]^ | No | [55] |
Sod1 −/− | C57BL/6 | 18 | N/A - 20.8 ± 0.7 months [versus 29.8 ± 2.1 monthsC1]^ | Yes | [55] |
Catalase | Â | Â | Â | Â | Â |
Cat Tg | C57BL/6 (male) | 44 | 1,099 d [versus 1,090 d] | No | [50] |
Cat Tg p | C57BL/6 < | 44 | N/A (only a survivor curve was given - clear values not provided) | No’ | [56] |
Cat Tg m | C57BL/6 < | 62 | N/A | Yes - increased median and maximum lifespan | [56] |
Cat Tg n | C57BL/6 < | 78 | N/A | No | [56] |
Glutathione peroxidase 4 | Â | Â | Â | Â | Â |
Gpx4 Tg | C57BL/6 (males) | 18 | 1,072 d (1,062 to 1,080) [versus 1,106 d (1,026 to 1,161)] | No | [51] |
Gpx4 +/− | C57BL/6 (females) | 50 | 1,126 ± 20 d [versus 1,145 ± 9 d] | Yes - significant increase in mean lifespan only | [57] |
Glutathione peroxidase 1 | Â | Â | Â | Â | Â |
Gpx1 −/− | C57BL/6 (females) | 59 | 1,063 d (1,031 to 1,183) [versus 1,091 d (1,040 to 1,188)] | No | [58] |
Thioredoxin 1 | Â | Â | Â | Â | Â |
Trx1 Tg | C57BL/6 (males)> | 41 | 1,134 d [versus 1,159 d] | No# | [59] |
Trx1 Tg | C57BL/6 (males)> | 60 | 1,151 d [versus 1,143 d] | No# | [59] |
Trx1 Tg | C57BL/6 (females) | 40 | 1,152 d [versus 1,230 d] | No | [59] |
Thioredoxin 2 | Â | Â | Â | Â | Â |
Trx2 +/− | Mix of C57BL/6 J & 129 (females) | 26 | 1,059 d (1,020 to 1,139) [versus 1,186 d (1,086 to 1,359)] | No | [51] |
Methionine sulfoxide reductase | Â | Â | Â | Â | Â |
MsrA −/− | Mix of C57BL/6 J & 129 (males) | 25 | 1,157 d (1,105 to 1,203) [versus 1,140 d (1,092 to 1,204)]C2 | No | [60] |
MsrA −/− | C57BL/6 J | 17 | N/A - 409 ± 33 d [versus 680 ± 71 d]^ | Yes - increase in mean lifespan | [61] |
MsrA +/− | C57BL/6 J | 8 | N/A - 672 ± 80 d [versus 680 ± 71 d]^ | No | [61] |
Multiple gene manipulations: | Â | Â | Â | Â | Â |
Sod1 Tg / Sod2 Tg | C57BL/6 (males) | 54 | 1,075 d [versus 1,090 d] | No | [50] |
S od1 −/− / S od2 +/− | C57BL/6 | 11 | 886 d (817 to 883) [versus 1,076 d (1,035 to 1,298)] | Yes | [51] |
Sod1 Tg / Cat Tg | C57BL/6 (males) | 47 | 1,098 d [versus 1,090 d] | No | [50] |
Sod2 +/− / Gpx4 +/− | C57BL/6 | 11 | 1,025 d (938 to 1,099) [versus 1,076 d (1,035 to 1,298)] | No | [51] |
Sod2 +/− / Gpx1 +/− | C57BL/6 | 25 | 1,057 d (1,027 to 1,298) [versus 1,091 d (1,040 to 1,188)] | No | [58] |
Sod2 +/− /Gpx1 −/− | C57BL/6 | 33 | 1,121 d (1,069 to 1,248) [versus 1,091 d (1,040 to 1,188)] | No | [58] |
Sod1 −/− / Gpx1 −/− | C57BL/6 (males) | 11 | 828 d (799 to 868) [versus 1,076 d (1,035 to 1,298)] | Yes - decrease in mean lifespan | [51] |
Sod1 −/− / Gpx4 +/− | C57BL/6 (males) | 16 | 866 d (817 to 883 [versus 1,076 d (1,035 to 1,298)] | Yes - decrease in mean and median lifespan | [51] |
Gpx1 -/ / Gpx4 +/− | C57BL/6 | 40 | 1,124 d (1,086 to 1,359) [versus 1,076 d (1,035 to 1,298)] | No | [51] |